DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in ...

DNAPrint genomics Inc. said it would acquire some of the assets of Ellipsis Biotherapeutics Corp. in a stock deal valued at about $112,000. Ellipsis will sell its clinical genomics and genotyping ...

DNAPrint™ genomics, Inc. has announced that it has established DNAPrint Pharmaceuticals, Inc., a wholly owned pharmaceutical subsidiary focused on personalized medicine. “Since its inception, DNAPrint ...

DNAPrint Genomics Inc. Annual stock financials by MarketWatch. View the latest DNAG financial statements, income statements and financial ratios.

DNAPrint™ genomics, Inc., has acquired Kenna Technologies, Inc., of West Chester, Pa., a private company which builds computer models that mimic complex biological systems. Under terms of the ...

DNAPrint has a robust pipeline of near and long-term diagnostic products including a revolutionary test for early detection of diabetic complication. Protectin, trademark, a new way to monitor and ...

DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in ...

SARASOTA, Fla., June 22, 2006 (PRIMEZONE) -- DNAPrint Genomics, Inc. (OTCBB:DNAG) President and Chief Executive Officer Richard Gabriel told shareholders at the Annual Meeting today that the ...

DNAPrint genomics Inc. in Sarasota announced Wednesday that it has secured a commitment from La Jolla Cove Investors Inc. to invest up to $8 million in the company over approximately the next two ...

DNAPrint genomics, Inc. uses proprietary human genome research methods to develop genomic-based services and products. The Company introduced Ancestrybydna in the consumer market and DNAWitness in the ...

SARASOTA -- DNAPrint Genomics posted a loss of $906,292 during the first quarter as it continued efforts to milk profits out of its genetic testing products. The per-share measure of the loss is so ...

SARASOTA -- DNAPrint Genomics Inc. continued its financial losing streak in 2002, finishing the year $3.11 million in the red. That's compared with a $2.59 million loss in 2001. Since December 1998, ...